Turn to the nation's most objective and informative daily environmental news resource to learn how the United States and key players around the world are responding to the environmental...
Key Provision: ECHA publishes a preliminary list of 91 substances for priority risk evaluation under REACH.
What's Next: ECHA aims to finalize the list by the end of February. Each substance will be allocated to an EU member state body for evaluation.
BRUSSELS—The European Chemicals Agency (ECHA) Oct. 21 published a preliminary list of 91 hazardous substances for priority risk evaluation under the European Union’s REACH law.
ECHA said the substances have been prioritized because they are suspected of being persistent, bioaccumulative, and toxic, or of having endocrine disrupting or carcinogenic properties. The substances are also likely to have “wide dispersive or consumer uses,” ECHA said.
The substances were selected from dossiers submitted to ECHA by Nov. 30, 2010, the first registration deadline under REACH (Regulation No. 1907/2006 on the registration, evaluation, and authorization of chemicals). The November 2010 deadline applied to chemicals manufactured in, or imported into, the European Union in annual volumes of 1,000 metric tons or more, and to some hazardous substances at lower volumes.
Each substance will be allocated for evaluation to an EU member state authority.
ECHA said the objective is “clarification” of risks. Evaluations could result in requests for more information from registrants or, ultimately, measures to limit the use of certain substances.
However, a substance evaluation may conclude that “the substance does not constitute a risk and no further data is needed,” ECHA said.
Evaluation under REACH is a separate process from authorization, under which the most hazardous substances are added to a candidate list for potential bans, unless permission for a specific continued use is given.
ECHA said it will discuss the preliminary list of 91 substances with the responsible institutions in EU member states and with the ECHA Member State Committee.
ECHA said its aim is to finalize the evaluation list, known under REACH as the Community Rolling Action Plan (CoRAP), by the end of February 2012.
Evaluations will be done by EU countries in the period 2012-2014, ECHA said.
Information about the REACH Community Rolling Action Plan and a link to the list of 91 substances are available at http://www.echa.europa.eu/reach/evaluation/corap_en.asp.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)